0001474064-11-000025.txt : 20110719 0001474064-11-000025.hdr.sgml : 20110719 20110719160807 ACCESSION NUMBER: 0001474064-11-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110715 FILED AS OF DATE: 20110719 DATE AS OF CHANGE: 20110719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRANADILLO PEDRO P CENTRAL INDEX KEY: 0001217544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 11975338 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2011-07-15 0000890465 NPS PHARMACEUTICALS INC NPSP 0001217544 GRANADILLO PEDRO P 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Deferred Stock Units 2011-07-15 4 A 0 1577 0 A Common Stock 1577 5923 D Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock. Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company. /s/ Edward Stratemeier as Attorney-in-fact 2011-07-19